BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 33557693)

  • 1. Cerebral endothelial cell-derived small extracellular vesicles enhance neurovascular function and neurological recovery in rat acute ischemic stroke models of mechanical thrombectomy and embolic stroke treatment with tPA.
    Li C; Wang C; Zhang Y; Alsrouji OK; Chebl AB; Ding G; Jiang Q; Mayer SA; Lu M; Kole MK; Marin HL; Zhang L; Chopp M; Zhang ZG
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2090-2104. PubMed ID: 33557693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
    Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
    Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opening the window: Ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model.
    Esmaeeli-Nadimi A; Kennedy D; Allahtavakoli M
    Eur J Pharmacol; 2015 Oct; 764():55-62. PubMed ID: 26123846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke.
    Li C; Zhang L; Wang C; Teng H; Fan B; Chopp M; Zhang ZG
    Stroke; 2019 Sep; 50(9):2547-2554. PubMed ID: 31387512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small extracellular vesicles obtained from hypoxic mesenchymal stromal cells have unique characteristics that promote cerebral angiogenesis, brain remodeling and neurological recovery after focal cerebral ischemia in mice.
    Gregorius J; Wang C; Stambouli O; Hussner T; Qi Y; Tertel T; Börger V; Mohamud Yusuf A; Hagemann N; Yin D; Dittrich R; Mouloud Y; Mairinger FD; Magraoui FE; Popa-Wagner A; Kleinschnitz C; Doeppner TR; Gunzer M; Meyer HE; Giebel B; Hermann DM
    Basic Res Cardiol; 2021 Jun; 116(1):40. PubMed ID: 34105014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models.
    Qiu L; Cai Y; Geng Y; Yao X; Wang L; Cao H; Zhang X; Wu Q; Kong D; Ding D; Shi Y; Wang Y; Wu J
    Acta Biomater; 2022 Dec; 154():424-442. PubMed ID: 36367475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with N-acetyl-seryl-aspartyl-lysyl-proline and tissue plasminogen activator provides potent neuroprotection in rats after stroke.
    Zhang L; Chopp M; Teng H; Ding G; Jiang Q; Yang XP; Rhaleb NE; Zhang ZG
    Stroke; 2014 Apr; 45(4):1108-14. PubMed ID: 24549864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible Pluripotent Stem Cell-Derived Small Extracellular Vesicles Rejuvenate Senescent Blood-Brain Barrier to Protect against Ischemic Stroke in Aged Mice.
    Li Q; Niu X; Yi Y; Chen Y; Yuan J; Zhang J; Li H; Xia Y; Wang Y; Deng Z
    ACS Nano; 2023 Jan; 17(1):775-789. PubMed ID: 36562422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat.
    Ding G; Zhang Z; Chopp M; Li L; Zhang L; Li Q; Wei M; Jiang Q
    Neuroscience; 2014 Jun; 271():1-8. PubMed ID: 24769225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.
    Kaur J; Tuor UI; Zhao Z; Barber PA
    J Cereb Blood Flow Metab; 2011 Sep; 31(9):1874-85. PubMed ID: 21610723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
    Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
    Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
    Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
    Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ML351 and tissue plasminogen activator combination therapy in a rat model of focal embolic stroke.
    Cheng G; Zhao W; Xin Y; Huang G; Liu Y; Li Z; Zhan M; Li Y; Lu L; van Leyen K; Liu Y
    J Neurochem; 2021 May; 157(3):586-598. PubMed ID: 33481248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W; Hendren J; Qin XJ; Liu KJ
    Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Induce Ischemic Neuroprotection by Modulating Leukocytes and Specifically Neutrophils.
    Wang C; Börger V; Sardari M; Murke F; Skuljec J; Pul R; Hagemann N; Dzyubenko E; Dittrich R; Gregorius J; Hasenberg M; Kleinschnitz C; Popa-Wagner A; Doeppner TR; Gunzer M; Giebel B; Hermann DM
    Stroke; 2020 Jun; 51(6):1825-1834. PubMed ID: 32312217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The paradox of tPA in ischemic stroke: tPA knockdown following recanalization improves functional and histological outcomes.
    Challa SR; Nalamolu KR; Fornal CA; Baker IM; Mohandass A; Mada SR; Wang BC; Pinson DM; Lahoti S; Klopfenstein JD; Veeravalli KK
    Exp Neurol; 2024 Apr; 374():114727. PubMed ID: 38360257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small extracellular vesicles derived from cerebral endothelial cells with elevated microRNA 27a promote ischemic stroke recovery.
    Zhang Y; Liu Z; Chopp M; Millman M; Li Y; Cepparulo P; Kemper A; Li C; Zhang L; Zhang ZG
    Neural Regen Res; 2025 Jan; 20(1):224-233. PubMed ID: 38767487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
    J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.